EUVIMEDEUVIMED entdecken
Open Access

Predictors of 12-Month Recurrence of Hemoptysis after Bronchial Artery Embolization

Sareh Sadidi iD, Farzin Roozafzai iD, Sirous Nekooei iD, Lida Jarahi iD, Farzaneh Khoroushi iD

Archives of Iranian Medicine · 2025

DOI: 10.34172/aim.33457 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Iranian Medicine, 2025. Verfasst von Sareh Sadidi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Hemoptysis, Bronchial Arteries, Embolization, Therapeutic. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite the high success rate of bronchial artery embolization (BAE), hemoptysis probably recurs. This study investigated risk factors of 12-month hemoptysis recurrence after BAE in an Iranian population.

Methods

In this prospective cohort, we followed up 101 patients for 12 months after BAE. Outcome of interest was recurrence of hemoptysis. Target arteries were super-selectively catheterized and embolized with non-spherical polyvinyl alcohol particles (150–700 µm). Success of BAE was confirmed using post-BAE angiography. Independent t-test, and chi-square and Fisher’s exact test were used to compare variables between "recurrence" and "non-recurrence" groups. We investigated predictors of recurrent hemoptysis through univariate and multivariate logistic regression modeling. We analyzed receiver operating characteristic curve to find the optimal cutoff point for continuous risk factors. Recurrence-free rates stratified by risk factors were plotted against time using the Kaplan-Meier method.

Results

BAE was immediately successful in all patients. During the 12-month follow-up, hemoptysis recurred in 13.9% (95% CI: 8.2–21.6) of participants. Mean (±standard deviation) recurrence-free time was 6.9 (±3.3) months. Lung destruction (OR=5.40 [95% CI: 1.41–20.58], P value=0.013) and arterial diameter≥2 mm (12.51 [1.51–103.59], P value=0.019) were independent predictors of 12-month hemoptysis recurrence.

Conclusion

Patients with destroyed lungs and embolized arteries wider than 2.0 mm are at higher risk of hemoptysis recurrence in the first year after BAE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemoptysisBronchial ArteriesEmbolization, TherapeuticHumansMaleFemaleRecurrenceMiddle AgedProspective StudiesRisk FactorsAdultIranAgedLogistic ModelsFollow-Up StudiesTreatment OutcomeROC Curve

Stichwörter der Autor:innen

Bronchial artery embolizationHemoptysisRecurrenceRisk factor

Autor:innen und Institutionen

  • Department of Radiology, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Community Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

ORCID-Profile: Sareh Sadidi, Farzin Roozafzai, Sirous Nekooei, Lida Jarahi, Farzaneh Khoroushi

Zitieren

APA

Sadidi, S., Roozafzai, F., Nekooei, S., Jarahi, L., & Khoroushi, F. (2025). Predictors of 12-Month Recurrence of Hemoptysis after Bronchial Artery Embolization. Archives of Iranian Medicine. https://doi.org/10.34172/aim.33457

Vancouver

Sadidi S, Roozafzai F, Nekooei S, Jarahi L, Khoroushi F. Predictors of 12-Month Recurrence of Hemoptysis after Bronchial Artery Embolization. Archives of Iranian Medicine. 2025. doi:10.34172/aim.33457

BibTeX
@article{Sadidi2025,
  author = {Sadidi, Sareh and Roozafzai, Farzin and Nekooei, Sirous and Jarahi, Lida and Khoroushi, Farzaneh},
  title = {Predictors of 12-Month Recurrence of Hemoptysis after Bronchial Artery Embolization},
  journal = {Archives of Iranian Medicine},
  year = {2025},
  doi = {10.34172/aim.33457}
}
Kostenlos starten →